×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CRSP – crispr therapeutics ag - common shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CRSP
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/14
08:12 pm
crsp
A Look At CRISPR Therapeutics (CRSP) Valuation After Upsized US$550 Million Convertible Note Offering [Yahoo! Finance]
Low
Report
A Look At CRISPR Therapeutics (CRSP) Valuation After Upsized US$550 Million Convertible Note Offering [Yahoo! Finance]
3/13
10:26 am
crsp
Investors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know [Yahoo! Finance]
Low
Report
Investors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know [Yahoo! Finance]
3/11
05:01 pm
crsp
CRISPR Therapeutics (CRSP) Reports $116M FY25 Revenue Driven by CASGEVY Growth [Yahoo! Finance]
Low
Report
CRISPR Therapeutics (CRSP) Reports $116M FY25 Revenue Driven by CASGEVY Growth [Yahoo! Finance]
3/11
07:13 am
crsp
CRISPR Therapeutics Prices Upsized Convertible Senior Notes Offering [Yahoo! Finance]
Medium
Report
CRISPR Therapeutics Prices Upsized Convertible Senior Notes Offering [Yahoo! Finance]
3/11
07:00 am
crsp
CRISPR Therapeutics Prices Upsized Convertible Senior Notes Offering
Medium
Report
CRISPR Therapeutics Prices Upsized Convertible Senior Notes Offering
3/11
01:31 am
crsp
CRISPR Therapeutics Raises US$350m As Undervalued Shares Draw Investor Focus [Yahoo! Finance]
Medium
Report
CRISPR Therapeutics Raises US$350m As Undervalued Shares Draw Investor Focus [Yahoo! Finance]
3/10
04:03 pm
crsp
This Is Why CRISPR Therapeutics Stock Is Tumbling on Tuesday [Yahoo! Finance]
Medium
Report
This Is Why CRISPR Therapeutics Stock Is Tumbling on Tuesday [Yahoo! Finance]
3/10
08:23 am
crsp
Here is Why CRISPR Therapeutics (CRSP) Appears so Good [Yahoo! Finance]
Low
Report
Here is Why CRISPR Therapeutics (CRSP) Appears so Good [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
2/12/2026
04:30 pm
crsp
crispr therapeutics ag - common shares
MISS
Report
10.1%
crispr therapeutics ag - common shares
11/10/2025
08:00 am
crsp
crispr therapeutics ag - common shares
BEAT
Report
-6.2%
crispr therapeutics ag - common shares
8/4/2025
04:15 pm
crsp
crispr therapeutics ag - common shares
MISS
Report
-7.1%
crispr therapeutics ag - common shares
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/16
04:07 pm
crsp
Form 8-K CRISPR Therapeutics AG For: Mar 16
Low
Report
Form 8-K CRISPR Therapeutics AG For: Mar 16
3/12
05:35 pm
crsp
Form 4 CRISPR Therapeutics AG For: Mar 10 Filed by: KASINGER JAMES R.
Low
Report
Form 4 CRISPR Therapeutics AG For: Mar 10 Filed by: KASINGER JAMES R.
3/12
05:35 pm
crsp
Form 4 CRISPR Therapeutics AG For: Mar 10 Filed by: Kulkarni Samarth
Low
Report
Form 4 CRISPR Therapeutics AG For: Mar 10 Filed by: Kulkarni Samarth
3/11
07:08 am
crsp
Form 8-K CRISPR Therapeutics AG For: Mar 10
Medium
Report
Form 8-K CRISPR Therapeutics AG For: Mar 10
2/20
05:37 pm
crsp
Form 4 CRISPR Therapeutics AG For: Feb 18 Filed by: Kulkarni Samarth
Low
Report
Form 4 CRISPR Therapeutics AG For: Feb 18 Filed by: Kulkarni Samarth
2/20
05:36 pm
crsp
Form 4 CRISPR Therapeutics AG For: Feb 18 Filed by: KASINGER JAMES R.
Low
Report
Form 4 CRISPR Therapeutics AG For: Feb 18 Filed by: KASINGER JAMES R.
2/17
12:06 pm
crsp
Form SCHEDULE 13G/A CRISPR Therapeutics AG Filed by: ORBIS INVESTMENT MANAGEMENT LTD
Low
Report
Form SCHEDULE 13G/A CRISPR Therapeutics AG Filed by: ORBIS INVESTMENT MANAGEMENT LTD
2/12
04:59 pm
crsp
Form 10-K CRISPR Therapeutics AG For: Dec 31
Medium
Report
Form 10-K CRISPR Therapeutics AG For: Dec 31
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
11/19
CRISPR Therapeutics down 4% premarket on initial CTX001 data [Seeking Alpha]
19.1%
2/28 Can CRISPR Therapeutics Double Your Money in 2020? [The Motley Fool] 13.1%
10/28 Q3/2019 9/30/2019 EPS 2.400 ZacksConsensus N/A ActVsEst N/A - N/A 12.5%
8/5 Form 4 CRISPR Therapeutics AG For: Aug 01 Filed by: Ho Tony W 7.5%
2/7 First CRISPR Gene Editing Trial in Cancer Patients Shows Promising Results [The Motley Fool] 6.8%
12/2 Form 4 CRISPR Therapeutics AG For: Dec 01 Filed by: Kulkarni Samarth 6.3%
11/22 Form 8-K CRISPR Therapeutics AG For: Nov 19 6.1%
10/30 Crispr Therapeutics AG (NASDAQ: CRSP) was upgraded by analysts at TheStreet from a "d" rating to a "c" rating. 5.9%
6/6 Form 8-K CRISPR Therapeutics AG For: Jun 06 5.6%
4/24 Form DEF 14A CRISPR Therapeutics AG For: Jun 11 5.5%
2/28 Can CRISPR Therapeutics Double Your Money in 2020? [The Motley Fool] 13.1%
10/28 Q3/2019 9/30/2019 EPS 2.400 ZacksConsensus N/A ActVsEst N/A - N/A 12.5%
8/5 Form 4 CRISPR Therapeutics AG For: Aug 01 Filed by: Ho Tony W 7.5%
2/7 First CRISPR Gene Editing Trial in Cancer Patients Shows Promising Results [The Motley Fool] 6.8%
12/2 Form 4 CRISPR Therapeutics AG For: Dec 01 Filed by: Kulkarni Samarth 6.3%
11/22 Form 8-K CRISPR Therapeutics AG For: Nov 19 6.1%
10/30 Crispr Therapeutics AG (NASDAQ: CRSP) was upgraded by analysts at TheStreet from a "d" rating to a "c" rating. 5.9%
6/6 Form 8-K CRISPR Therapeutics AG For: Jun 06 5.6%
4/24 Form DEF 14A CRISPR Therapeutics AG For: Jun 11 5.5%
TOP News Decliners
11/20
CRISPR Therapeutics Announces Pricing of Public Offering of Common Shares
-10.6%
3/31 Form 8-K CRISPR Therapeutics AG For: Mar 31 -10.4%
8/3 Crispr Therapeutics AG (NASDAQ: CRSP) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -10.2%
12/27 Form 8-K CRISPR Therapeutics AG For: Dec 27 -7.5%
12/6 Crispr Therapeutics AG (NASDAQ: CRSP) had its "buy" rating re-affirmed by analysts at Wells Fargo & Co. -7.1%
2/21 Crispr Therapeutics AG (NASDAQ: CRSP) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. -6.5%
10/1 CRISPR Therapeutics to Present at Upcoming Investor Conferences -6.3%
9/25 Is CRISPR Therapeutics a Buy? [The Motley Fool] -5.9%
2/13 Crispr Therapeutics AG (NASDAQ: CRSP) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $72.50 price target on the stock. -5.6%
6/19 Form 4 CRISPR Therapeutics AG For: Jun 17 Filed by: Kulkarni Samarth -5.6%
3/31 Form 8-K CRISPR Therapeutics AG For: Mar 31 -10.4%
8/3 Crispr Therapeutics AG (NASDAQ: CRSP) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -10.2%
12/27 Form 8-K CRISPR Therapeutics AG For: Dec 27 -7.5%
12/6 Crispr Therapeutics AG (NASDAQ: CRSP) had its "buy" rating re-affirmed by analysts at Wells Fargo & Co. -7.1%
2/21 Crispr Therapeutics AG (NASDAQ: CRSP) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. -6.5%
10/1 CRISPR Therapeutics to Present at Upcoming Investor Conferences -6.3%
9/25 Is CRISPR Therapeutics a Buy? [The Motley Fool] -5.9%
2/13 Crispr Therapeutics AG (NASDAQ: CRSP) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $72.50 price target on the stock. -5.6%
6/19 Form 4 CRISPR Therapeutics AG For: Jun 17 Filed by: Kulkarni Samarth -5.6%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: